In light of the GEPIA2 analysis, some other tumors (BLCA, CESC, COAD, DLBC, GBM, LGG, LUAD, LUSC, OV, PRAD, READ, STAD, THYM, UCEC, and UCS) are high expressed of PSAT1 (Fig. S4), which bodes well for the possibility of studying PSAT1 as a biomarker in other tumors. This evidence concerns the gene PSAT1 and glioblastoma.